BioPharma Dive - Latest News

Biotech ‘megarounds’ hold steady as startups, VCs wait on IPOs

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed via rounds worth at least $100 million, which experts believe reflects a strategic shift.

Apr 3, 2025 - 12:04
 0
Biotech ‘megarounds’ hold steady as startups, VCs wait on IPOs

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed via rounds worth at least $100 million, which experts believe reflects a strategic shift.

Read More

Tags:

Previous Article

Skoda Elroq vRS unveiled with 340 miles of range

Next Article

How deepwater producers remain resilient amid fluctuating oil prices

Related Posts

Bristol Myers, bracing for key patent losses, deepens cost-cutting plan

Bristol Myers, bracing for key patent losses, deepens c...

Feb 9, 2025  0

Roche launches new Boston center; NIH centralizes peer review

Roche launches new Boston center; NIH centralizes peer ...

Mar 7, 2025  0

Vertex COO Arbuckle to step down later this year

Vertex COO Arbuckle to step down later this year

Feb 11, 2025  0